Pipeline Reporting

Proactive Pipeline Assessment

Pre-Launch Impact Analysis
  • Assessment of current patient base and the likely impact of new therapies to the health plan.


Pre-Launch Clinical Criteria Development

Ensure readiness for the launch of new therapies.
  • Monitor clinical trials and advise the health plan related to potential place in therapy for new products.
  • Monitor pipeline to identify opportunities for preferred drug strategies based on the likely place in therapy of a new product.
  • Work with health plan to develop clinical criteria prior to launch.


Pre-Launch Step-Therapy Analysis

Assist in developing strategies to utilize lower cost alternatives prior to biologic or specialty therapies.
  • Generics
  • Traditional therapy prior to biologic/specialty.